Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Ptc Therapeutics (PTCT) Other Non Operating Income (2016 - 2025)

Ptc Therapeutics (PTCT) has 14 years of Other Non Operating Income data on record, last reported at $6.5 million in Q3 2025.

  • For Q3 2025, Other Non Operating Income rose 447.33% year-over-year to $6.5 million; the TTM value through Sep 2025 reached $7.2 million, up 105.48%, while the annual FY2025 figure was -$18.1 million, 376.38% down from the prior year.
  • Other Non Operating Income reached $6.5 million in Q3 2025 per PTCT's latest filing, up from -$6.3 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $35.1 million in Q4 2022 and bottomed at -$128.7 million in Q4 2023.
  • Average Other Non Operating Income over 5 years is -$13.2 million, with a median of -$4.2 million recorded in 2024.
  • Peak YoY movement for Other Non Operating Income: tumbled 1184.56% in 2022, then soared 447.33% in 2025.
  • A 5-year view of Other Non Operating Income shows it stood at -$31.4 million in 2021, then soared by 212.02% to $35.1 million in 2022, then crashed by 466.24% to -$128.7 million in 2023, then surged by 106.88% to $8.8 million in 2024, then decreased by 26.53% to $6.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non Operating Income were $6.5 million in Q3 2025, -$6.3 million in Q1 2025, and $8.8 million in Q4 2024.